These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1075 related items for PubMed ID: 36620648

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.
    Wu ZF, Su WT, Chen S, Xu BD, Zong GJ, Fang CM, Huang Z, Hu XJ, Wu GY, Ma XL.
    Ther Clin Risk Manag; 2023; 19():699-712. PubMed ID: 37641783
    [Abstract] [Full Text] [Related]

  • 3. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L, Zhang J, Huang Q, Cui R, Chen J.
    BMC Cardiovasc Disord; 2023 Apr 17; 23(1):198. PubMed ID: 37069503
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
    Liu Y, Ye T, Chen K, Wu G, Xia Y, Wang X, Zong G.
    Front Cardiovasc Med; 2022 Apr 17; 9():966299. PubMed ID: 36003914
    [Abstract] [Full Text] [Related]

  • 7. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.
    Qiu H, Zhu Y, Shen G, Wang Z, Li W.
    Clin Interv Aging; 2023 Apr 17; 18():453-465. PubMed ID: 36987461
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
    Wang L, Wang Y, Wang W, Wang Z.
    Sci Rep; 2024 Jun 02; 14(1):12634. PubMed ID: 38824158
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Establishment and validation of a clinical nomogram model based on serum YKL-40 to predict major adverse cardiovascular events during hospitalization in patients with acute ST-segment elevation myocardial infarction.
    Fang C, Li J, Wang W, Wang Y, Chen Z, Zhang J.
    Front Med (Lausanne); 2023 Jun 02; 10():1158005. PubMed ID: 37283624
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a nomogram model for predicting in-hospital mortality risk in patients with acute ST-elevation myocardial infarction and acute heart failure post-PCI.
    Yu F, Xu Y, Peng J.
    Scand Cardiovasc J; 2024 Dec 02; 58(1):2387001. PubMed ID: 39092557
    [Abstract] [Full Text] [Related]

  • 14. Development and validation of a prognostic model for predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).
    Zhang L, Liu Z, Zhu Y, Wu M, Huang H, Yang W, Peng K, Zeng J.
    J Cardiothorac Surg; 2024 Mar 30; 19(1):163. PubMed ID: 38555468
    [Abstract] [Full Text] [Related]

  • 15. Construction and validation of a predictive model for major adverse cardiovascular events in the long term after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Yang Y, Yin X, Zhang Y, Ren L.
    Coron Artery Dis; 2024 Sep 01; 35(6):471-480. PubMed ID: 38656258
    [Abstract] [Full Text] [Related]

  • 16. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Ying C, Liu CF, Guo DQ, Du ZR, Wei YJ.
    Clinics (Sao Paulo); 2023 Sep 01; 78():100306. PubMed ID: 37949037
    [Abstract] [Full Text] [Related]

  • 17. The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention.
    Wang Z, Peng J.
    Sci Rep; 2023 Mar 28; 13(1):5084. PubMed ID: 36977721
    [Abstract] [Full Text] [Related]

  • 18. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
    Liu H, Su Y, Shen J, Jiao Y, Li Y, Liu B, Hou X, Jin Q, Chen Y, Sun Z, Xi Q, Feng B, Fu Z.
    ESC Heart Fail; 2024 Apr 28; 11(2):937-949. PubMed ID: 38224955
    [Abstract] [Full Text] [Related]

  • 19. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model.
    Ye Z, Xu Y, Tang L, Wu M, Wu B, Zhu T, Wang J.
    Cardiovasc Diabetol; 2023 Apr 13; 22(1):87. PubMed ID: 37055777
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of carotid intima-media thickness and plasma homocysteine in acute ST-segment elevation myocardial infarction.
    Ou Q, Zhang J, Wen X, Yang L, Tao L.
    Cardiovasc Diagn Ther; 2023 Dec 15; 13(6):917-928. PubMed ID: 38162099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.